Study
Bryan Johnson highlights LDL reduction and vascular-event evidence
NEW BIOMARKER/EVIDENCE POST: Johnson cites 49 randomized trials involving 312,175 people and says each 39 mg/dL LDL reduction tracked with about 23% fewer major vascular events; his nutrition estimate is not a personal trial.
Summary Does lowering LDL cholesterol reduce the risk of heart attacks and strokes? Show / hide ↓
Researchers combined results from 49 randomized trials, involving 312,175 people. Randomized trials assign people to different treatments by chance, making comparisons fairer. They found that lowering LDL cholesterol, often called bad cholesterol, by 39 mg/dL was linked with about 23% fewer major vascular events, such as heart attacks, strokes, or cardiovascular deaths. The evidence supports LDL lowering in general, but it does not prove that the specific mix of fiber, nuts, plant protein, and plant sterols produces the same benefit. The post also gives no personal before-and-after results or detailed diet plan.
What this means for you: Lowering LDL is a reasonable health goal to discuss with a clinician, through diet, medicine, or both. Do not treat the proposed food combination as proven to prevent heart attacks or strokes, because that specific approach was not tested here.
solid evidenceOn 26 August 2026, Bryan Johnson highlighted LDL cholesterol as an actionable blood measure. He cited a meta-analysis of 49 randomized trials involving 312,175 people and stated that each 39 mg/dL (1 mmol/L) LDL reduction was associated with about 23% fewer major vascular events, including heart attacks, strokes, and cardiovascular death. He then stated that a combination of viscous fiber, nuts, plant protein, and plant sterols can reduce LDL by 13–14% over 6 months, and that medication can also play a role. The post does not provide a detailed dietary protocol, trial names, participant characteristics, confidence intervals, or a personal before-and-after result. The cited JAMA meta-analysis supports the relationship between LDL lowering and vascular events across several interventions, but it does not show that Johnson’s proposed food combination produces the same event reduction. A commenter identified missing stratification for physical activity, triglyceride-to-HDL ratio, concurrent medication, smoking, and alcohol. That comment is incomplete on the page and is not an independent analysis. This item is an evidence summary and biomarker-position post, not a new self-experiment. The 312,175 figure is the meta-analysis population, not Johnson’s N.
Nutrition can lower LDL 13–14% over 6 months with viscous fiber, nuts, plant protein, and plant sterols. Medications can also serve a role.
The underlying JAMA meta-analysis is a human RCT meta-analysis, but it concerns LDL-lowering interventions rather than a supplement ingredient in the database: https://pubmed.ncbi.nlm.nih.gov/27673306/. No ingredient evidence-grade upgrade follows. The post’s listed reply from A&Z MD raises residual-confounding and stratification questions; it does not overturn the randomized-trial evidence.
Cited by
2 encyclopedia entries reference this study.